Skip to main content
NCBI home page
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1991 Nov;44(11):896–899. doi: 10.1136/jcp.44.11.896

Endocervical carcinoma and precursor lesions: c-myc expression and the demonstration of field changes.

S V Polacarz 1, J Darne 1, E G Sheridan 1, R Ginsberg 1, F Sharp 1
PMCID: PMC496625  PMID: 1752978

Abstract

The monoclonal antibody Myc 1-6E10 was used in an immunocytochemical technique to examine the expression of the c-myc oncogene in normal endocervices and those with glandular intraepithelial neoplasia and invasive malignancy. Eleven of 14 normal endocervical biopsy specimens did not express the gene, while three showed nuclear, or light basal cytoplasmic localisation of the gene product, or both. All but one of 14 cases of low and high grade glandular intraepithelial neoplasia, and all 17 cases of invasive adenocarcinoma, showed a pan-cellular pattern of immunostaining. Of considerable additional interest was the demonstration of field changes in morphologically normal glandular epithelium in those biopsy specimens with concurrent cervical glandular intraepithelial neoplasia or adenocarcinoma. This was manifest as increased concentrations of myc proteins compared with normal tissues. These results further support the role of the c-myc gene in oncogenesis, and in the light of field changes, suggest possible difficulties in the clinical management of this group of patients.

Full text

PDF
896

Images in this article

897Image
on p.897
897Image
on p.897
897Image
on p.897
897Image
on p.897

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Boon M. E., Baak J. P., Kurver P. J., Overdiep S. H., Verdonk G. W. Adenocarcinoma in situ of the cervix: an underdiagnosed lesion. Cancer. 1981 Aug 1;48(3):768–773. doi: 10.1002/1097-0142(19810801)48:3<768::aid-cncr2820480318>3.0.co;2-l. [DOI] [PubMed] [Google Scholar]
  2. Brown J. V., Peters W. A., Corwin D. J. Invasive carcinoma after cone biopsy for cervical intraepithelial neoplasia. Gynecol Oncol. 1991 Jan;40(1):25–28. doi: 10.1016/0090-8258(91)90079-k. [DOI] [PubMed] [Google Scholar]
  3. Brown L. J., Griffin N. R., Wells M. Cytoplasmic reactivity with the monoclonal antibody HMFG1 as a marker of cervical glandular atypia. J Pathol. 1987 Mar;151(3):203–208. doi: 10.1002/path.1711510308. [DOI] [PubMed] [Google Scholar]
  4. Christopherson W. M., Nealon N., Gray L. A., Sr Noninvasive precursor lesions of adenocarcinoma and mixed adenosquamous carcinoma of the cervix uteri. Cancer. 1979 Sep;44(3):975–983. doi: 10.1002/1097-0142(197909)44:3<975::aid-cncr2820440327>3.0.co;2-7. [DOI] [PubMed] [Google Scholar]
  5. Ciclitira P. J., Macartney J. C., Evan G. Expression of c-myc in non-malignant and pre-malignant gastrointestinal disorders. J Pathol. 1987 Apr;151(4):293–296. doi: 10.1002/path.1711510409. [DOI] [PubMed] [Google Scholar]
  6. Dabbs D. J., Geisinger K. R., Norris H. T. Intermediate filaments in endometrial and endocervical carcinomas. The diagnostic utility of vimentin patterns. Am J Surg Pathol. 1986 Aug;10(8):568–576. doi: 10.1097/00000478-198608000-00007. [DOI] [PubMed] [Google Scholar]
  7. Darne J. F., Polacarz S. V., Sheridan E., Anderson D., Ginsberg R., Sharp F. Nucleolar organiser regions in adenocarcinoma in situ and invasive adenocarcinoma of the cervix. J Clin Pathol. 1990 Aug;43(8):657–660. doi: 10.1136/jcp.43.8.657. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Davis J. R., Moon L. B. Increased incidence of adenocarcinoma of uterine cervix. Obstet Gynecol. 1975 Jan;45(1):79–83. [PubMed] [Google Scholar]
  9. Di Luca D., Costa S., Monini P., Rotola A., Terzano P., Savioli A., Grigioni W., Cassai E. Search for human papillomavirus, herpes simplex virus and c-myc oncogene in human genital tumors. Int J Cancer. 1989 Apr 15;43(4):570–577. doi: 10.1002/ijc.2910430407. [DOI] [PubMed] [Google Scholar]
  10. Evan G. I., Lewis G. K., Ramsay G., Bishop J. M. Isolation of monoclonal antibodies specific for human c-myc proto-oncogene product. Mol Cell Biol. 1985 Dec;5(12):3610–3616. doi: 10.1128/mcb.5.12.3610. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Gallup D. G., Abell M. R. Invasive adenocarcinoma of the uterine cervix. Obstet Gynecol. 1977 May;49(5):596–603. [PubMed] [Google Scholar]
  12. Goyette M., Petropoulos C. J., Shank P. R., Fausto N. Expression of a cellular oncogene during liver regeneration. Science. 1983 Feb 4;219(4584):510–512. doi: 10.1126/science.6297003. [DOI] [PubMed] [Google Scholar]
  13. Hendy-Ibbs P., Cox H., Evan G. I., Watson J. V. Flow cytometric quantitation of DNA and c-myc oncoprotein in archival biopsies of uterine cervix neoplasia. Br J Cancer. 1987 Mar;55(3):275–282. doi: 10.1038/bjc.1987.53. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Hughes R. G., Neill W. A., Norval M. Papillomavirus and c-myc antigen expression in normal and neoplastic cervical epithelium. J Clin Pathol. 1989 Jan;42(1):46–51. doi: 10.1136/jcp.42.1.46. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Koda T., Matsushima S., Sasaki A., Danjo Y., Kakinuma M. c-myc Gene amplification in primary stomach cancer. Jpn J Cancer Res. 1985 Jul;76(7):551–554. [PubMed] [Google Scholar]
  16. Lachman H. M., Skoultchi A. I. Expression of c-myc changes during differentiation of mouse erythroleukaemia cells. Nature. 1984 Aug 16;310(5978):592–594. doi: 10.1038/310592a0. [DOI] [PubMed] [Google Scholar]
  17. Müller R., Slamon D. J., Tremblay J. M., Cline M. J., Verma I. M. Differential expression of cellular oncogenes during pre- and postnatal development of the mouse. Nature. 1982 Oct 14;299(5884):640–644. doi: 10.1038/299640a0. [DOI] [PubMed] [Google Scholar]
  18. Ocadiz R., Sauceda R., Cruz M., Graef A. M., Gariglio P. High correlation between molecular alterations of the c-myc oncogene and carcinoma of the uterine cervix. Cancer Res. 1987 Aug 1;47(15):4173–4177. [PubMed] [Google Scholar]
  19. PEETE C. H., Jr, CARTER F. B., CHERNY W. B., PARKER R. T. FOLLOW-UP OF PATIENTS WITH ADENOCARCINOMA OF THE CERVIX AND CERVICAL STUMP. Am J Obstet Gynecol. 1965 Oct 1;93:343–356. doi: 10.1016/0002-9378(65)90063-3. [DOI] [PubMed] [Google Scholar]
  20. Pfeifer-Ohlsson S., Goustin A. S., Rydnert J., Wahlström T., Bjersing L., Stehelin D., Ohlsson R. Spatial and temporal pattern of cellular myc oncogene expression in developing human placenta: implications for embryonic cell proliferation. Cell. 1984 Sep;38(2):585–596. doi: 10.1016/0092-8674(84)90513-0. [DOI] [PubMed] [Google Scholar]
  21. Polacarz S. V., Hey N. A., Stephenson T. J., Hill A. S. C-myc oncogene product P62c-myc in ovarian mucinous neoplasms: immunohistochemical study correlated with malignancy. J Clin Pathol. 1989 Feb;42(2):148–152. doi: 10.1136/jcp.42.2.148. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Reitsma P. H., Rothberg P. G., Astrin S. M., Trial J., Bar-Shavit Z., Hall A., Teitelbaum S. L., Kahn A. J. Regulation of myc gene expression in HL-60 leukaemia cells by a vitamin D metabolite. Nature. 1983 Dec 1;306(5942):492–494. doi: 10.1038/306492a0. [DOI] [PubMed] [Google Scholar]
  23. Riou G., Barrois M., Lê M. G., George M., Le Doussal V., Haie C. C-myc proto-oncogene expression and prognosis in early carcinoma of the uterine cervix. Lancet. 1987 Apr 4;1(8536):761–763. doi: 10.1016/s0140-6736(87)92795-4. [DOI] [PubMed] [Google Scholar]
  24. Riou G., Sheng Z. M., Zhou D., Lusinchi A., Le Doussal V., Barrois M. Les proto-oncogènes c-myc et c-Ha-ras dans les cancers du col de l'utérus: intérêt pronostique. Bull Cancer. 1990;77(4):341–347. [PubMed] [Google Scholar]
  25. Rollason T. P., Byrne P., Williams A., Brown G. Expression of epithelial membrane and 3-fucosyl-N-acetyllactosamine antigens in cervix uteri with particular reference to adenocarcinoma in situ. J Clin Pathol. 1988 May;41(5):547–552. doi: 10.1136/jcp.41.5.547. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Sikora K., Evan G., Watson J. Oncogenes and germ cell tumours. Int J Androl. 1987 Feb;10(1):57–67. doi: 10.1111/j.1365-2605.1987.tb00166.x. [DOI] [PubMed] [Google Scholar]
  27. Sowani A., Ong G., Dische S., Quinn C., White J., Soutter P., Waxman J., Sikora K. c-myc oncogene expression and clinical outcome in carcinoma of the cervix. Mol Cell Probes. 1989 Jun;3(2):117–123. doi: 10.1016/0890-8508(89)90022-4. [DOI] [PubMed] [Google Scholar]
  28. Stewart J., Evan G., Watson J., Sikora K. Detection of the c-myc oncogene product in colonic polyps and carcinomas. Br J Cancer. 1986 Jan;53(1):1–6. doi: 10.1038/bjc.1986.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Teshima S., Shimosato Y., Kishi K., Kasamatsu T., Ohmi K., Uei Y. Early stage adenocarcinoma of the uterine cervix. Histopathologic analysis with consideration of histogenesis. Cancer. 1985 Jul 1;56(1):167–172. doi: 10.1002/1097-0142(19850701)56:1<167::aid-cncr2820560126>3.0.co;2-t. [DOI] [PubMed] [Google Scholar]
  30. Vesterinen E., Forss M., Nieminen U. Increase of cervical adenocarcinoma: a report of 520 cases of cervical carcinoma including 112 tumors with glandular elements. Gynecol Oncol. 1989 Apr;33(1):49–53. doi: 10.1016/0090-8258(89)90602-1. [DOI] [PubMed] [Google Scholar]
  31. Wells M., Brown L. J. Glandular lesions of the uterine cervix: the present state of our knowledge. Histopathology. 1986 Aug;10(8):777–792. doi: 10.1111/j.1365-2559.1986.tb02578.x. [DOI] [PubMed] [Google Scholar]
  32. Williams A. R., Piris J., Wyllie A. H. Immunohistochemical demonstration of altered intracellular localization of the C-Myc oncogene product in human colorectal neoplasms. J Pathol. 1990 Apr;160(4):287–293. doi: 10.1002/path.1711600404. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES